Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sadat

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Human Gene Therapy|June 14, 2003
Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface markerMohammed A Sadat, Nancy Pech, So Saulnier, et al.
Molecular Pharmaceutics|May 24, 2024
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal CancerSams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytesS Suzuki, A Kumatori, I A Haagen, et al.
Drug Delivery and Translational Research|January 29, 2025
Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeuticsParnian Mehinrad, Ahmed Abdelfattah, Sams M A Sadat, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2017
Real-Time PCR: an Effective Tool for Measuring Transduction Efficiency in Human Hematopoietic Progenitor CellsAnthony D Villella, Jing Yao, Robert R Getty, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2021
A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3'-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancerSams M A Sadat, Igor M Paiva, Zahra Shire, et al.
Frontiers in Oncology|January 10, 2022
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA DamageSams M A Sadat, Melinda Wuest, Igor M Paiva, et al.
Gene Therapy|August 7, 2009
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiationM A Sadat, S Dirscherl, L Sastry, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
The Journal of Allergy and Clinical Immunology|April 2, 2013
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosisElizabeth P Sampaio, Amy P Hsu, Joseph Pechacek, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|June 14, 2003
Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface markerMohammed A Sadat, Nancy Pech, So Saulnier, et al.
Molecular Pharmaceutics|May 24, 2024
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal CancerSams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytesS Suzuki, A Kumatori, I A Haagen, et al.
Drug Delivery and Translational Research|January 29, 2025
Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeuticsParnian Mehinrad, Ahmed Abdelfattah, Sams M A Sadat, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2017
Real-Time PCR: an Effective Tool for Measuring Transduction Efficiency in Human Hematopoietic Progenitor CellsAnthony D Villella, Jing Yao, Robert R Getty, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2021
A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3'-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancerSams M A Sadat, Igor M Paiva, Zahra Shire, et al.
Frontiers in Oncology|January 10, 2022
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA DamageSams M A Sadat, Melinda Wuest, Igor M Paiva, et al.
Gene Therapy|August 7, 2009
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiationM A Sadat, S Dirscherl, L Sastry, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
The Journal of Allergy and Clinical Immunology|April 2, 2013
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosisElizabeth P Sampaio, Amy P Hsu, Joseph Pechacek, et al.
Pageof 4